(Q54150263)

English

Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration. (English)

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

S Eksborg

1

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

U Stendahl

2

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

U Lönroth

3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

publication date

1 January 1986

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

30

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

5

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

629-631

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

https://scigraph.springernature.com/pub.10.1007/bf00542426

0 references

Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical toxicity of 4'-epi-doxorubicin (epirubicin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic study of i.v. infusions of adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin—A Review

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of 4'-epi-doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin. A new anticancer drug with significant clinical activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3463510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00542426

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3463510

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54150263&oldid=2143319192"